- Investing Ideas
- Indian Pharmaceuticals & Biotech Low-Risk Leaders
Indian Pharmaceuticals & Biotech Low-Risk Leaders
Results
3
0 new
Every great portfolio needs a good foundation. Our selection of stocks can help you lower your risk without sacrificing your returns. Invest in the market's most resilient companies with strong balance sheets and the lowest risk scores in our model.
3 companies
Shilpa Medicare
Market Cap: ₹159.3b
Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
530549
₹814.50
7D
-0.9%
1Y
91.8%
Granules India
Market Cap: ₹212.7b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹858.45
7D
0.04%
1Y
87.4%
Neuland Laboratories
Market Cap: ₹298.9b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,294.80
7D
-0.07%
1Y
68.0%